ELDN
Eledon Pharmaceuticals, Inc.NASDAQHealthcare$3.07+0.65%ClosedMarket Cap: $184.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.70
P/S
0.00
EV/EBITDA
-2.32
DCF Value
$0.24
FCF Yield
-33.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-46.5%
ROA
-19.2%
ROIC
-37.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-21.5M | $-10.4M | $-0.14 | — |
| FY 2025 | $0.00 | NaN% | $-83.3M | $-45.6M | $-0.56 | — |
| Q3 2025 | $0.00 | NaN% | $-19.1M | $-17.5M | $-0.23 | — |
| Q2 2025 | $0.00 | NaN% | $-24.7M | $-11.2M | $-0.15 | — |
| Q1 2025 | $0.00 | NaN% | $-18.0M | $-6.5M | $-0.08 | — |
| Q4 2024 | $0.00 | -Infinity% | $-24.7M | $-44.6M | $-0.75 | — |
| FY 2024 | $0.00 | -Infinity% | $-70.6M | $-36.2M | $-0.75 | — |
| Q3 2024 | $0.00 | -Infinity% | $-20.5M | $77.0M | $-0.32 | — |
| Q2 2024 | $0.00 | -Infinity% | $-14.5M | $-44.9M | $-1.06 | — |
| Q1 2024 | $0.00 | -Infinity% | $-10.9M | $-23.6M | $-0.79 | — |
| Q4 2023 | $0.00 | -Infinity% | $-10.3M | $-85.8M | $-3.55 | — |
| FY 2023 | $0.00 | -Infinity% | $-43.0M | $-116.5M | $-1.64 | — |